These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11212095)

  • 1. General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.
    Chollet AM; Le Diguarher T; Murray L; Bertrand M; Tucker GC; Sabatini M; Pierré A; Atassi G; Bonnet J; Casara P
    Bioorg Med Chem Lett; 2001 Feb; 11(3):295-9. PubMed ID: 11212095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-phase synthesis of alpha-substituted 3-bisarylthio N-hydroxy propionamides as specific MMP inhibitors.
    Chollet AM; Le Diguarher T; Kucharczyk N; Loynel A; Bertrand M; Tucker G; Guilbaud N; Burbridge M; Pastoureau P; Fradin A; Sabatini M; Fauchère JL; Casara P
    Bioorg Med Chem; 2002 Mar; 10(3):531-44. PubMed ID: 11814839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.
    Le Diguarher T; Chollet AM; Bertrand M; Hennig P; Raimbaud E; Sabatini M; Guilbaud N; Pierré A; Tucker GC; Casara P
    J Med Chem; 2003 Aug; 46(18):3840-52. PubMed ID: 12930146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.
    Curtin ML; Florjancic AS; Heyman HR; Michaelides MR; Garland RB; Holms JH; Steinman DH; Dellaria JF; Gong J; Wada CK; Guo Y; Elmore IB; Tapang P; Albert DH; Magoc TJ; Marcotte PA; Bouska JJ; Goodfellow CL; Bauch JL; Marsh KC; Morgan DW; Davidsen SK
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1557-60. PubMed ID: 11412980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.
    Wada CK; Holms JH; Curtin ML; Dai Y; Florjancic AS; Garland RB; Guo Y; Heyman HR; Stacey JR; Steinman DH; Albert DH; Bouska JJ; Elmore IN; Goodfellow CL; Marcotte PA; Tapang P; Morgan DW; Michaelides MR; Davidsen SK
    J Med Chem; 2002 Jan; 45(1):219-32. PubMed ID: 11754593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonists.
    Kopka IE; Lin LS; Mumford RA; Lanza T; Magriotis PA; Young D; DeLaszlo SE; MacCoss M; Mills SG; Van Riper G; McCauley E; Lyons K; Vincent S; Egger LA; Kidambi U; Stearns R; Colletti A; Teffera Y; Tong S; Owens K; Levorse D; Schmidt JA; Hagmann WK
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2415-8. PubMed ID: 12161146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.
    Hoffman A; Qadri B; Frant J; Katz Y; Bhusare SR; Breuer E; Hadar R; Reich R
    J Med Chem; 2008 Mar; 51(5):1406-14. PubMed ID: 18257543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.
    Song J; Peng P; Chang J; Liu MM; Yu JM; Zhou L; Sun X
    Bioorg Med Chem Lett; 2016 May; 26(9):2174-8. PubMed ID: 27038494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondrocytes and antirheumatic drugs.
    Raiss RX; Karbowski A; Aigner T; Schleyerbach R
    J Rheumatol Suppl; 1995 Feb; 43():152-4. PubMed ID: 7538587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress towards water-soluble triazole-based selective MMP-2 inhibitors.
    Fabre B; Filipiak K; Zapico JM; Díaz N; Carbajo RJ; Schott AK; Martínez-Alcázar MP; Suárez D; Pineda-Lucena A; Ramos A; de Pascual-Teresa B
    Org Biomol Chem; 2013 Oct; 11(38):6623-41. PubMed ID: 23989288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short entry to alpha-substituted gamma-alkylidene pentenolides. Synthesis and preliminary biological evaluation of novel gelastatin analogues.
    Pavlík J; Snajdr I; Kunes J; Spulák M; Pour M
    J Org Chem; 2009 Jan; 74(2):703-9. PubMed ID: 19143092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity.
    Zhang H; Wang X; Mao J; Huang Y; Xu W; Duan Y; Zhang J
    Bioorg Med Chem; 2018 Aug; 26(15):4363-4374. PubMed ID: 30093347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New derivatives of aryl-propionic acid. Synthesis and biological evaluation.
    Vasincu I; Apotrosoaei M; Tuchiluş C; Pânzariu AT; Dragostin O; Lupaşcu D; Profire L
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):532-7. PubMed ID: 24340542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and activity of selective MMP inhibitors with an aryl backbone.
    Barta TE; Becker DP; Bedell LJ; De Crescenzo GA; McDonald JJ; Munie GE; Rao S; Shieh HS; Stegeman R; Stevens AM; Villamil CI
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2815-7. PubMed ID: 11133099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.
    Becker DP; DeCrescenzo G; Freskos J; Getman DP; Hockerman SL; Li M; Mehta P; Munie GE; Swearingen C
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2723-5. PubMed ID: 11591510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.
    Becker DP; Barta TE; Bedell LJ; Boehm TL; Bond BR; Carroll J; Carron CP; Decrescenzo GA; Easton AM; Freskos JN; Funckes-Shippy CL; Heron M; Hockerman S; Howard CP; Kiefer JR; Li MH; Mathis KJ; McDonald JJ; Mehta PP; Munie GE; Sunyer T; Swearingen CA; Villamil CI; Welsch D; Williams JM; Yu Y; Yao J
    J Med Chem; 2010 Sep; 53(18):6653-80. PubMed ID: 20726512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors.
    Zask A; Gu Y; Albright JD; Du X; Hogan M; Levin JI; Chen JM; Killar LM; Sung A; DiJoseph JF; Sharr MA; Roth CE; Skala S; Jin G; Cowling R; Mohler KM; Barone D; Black R; March C; Skotnicki JS
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1487-90. PubMed ID: 12668018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
    Nuti E; Casalini F; Avramova SI; Santamaria S; Cercignani G; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Tuccinardi T; Martinelli A; Lim NH; Visse R; Nagase H; Rossello A
    J Med Chem; 2009 Aug; 52(15):4757-73. PubMed ID: 19606871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors.
    Kaplancikli ZA; Altıntop MD; Atli O; Sever B; Baysal M; Temel HE; Demirci F; Ozdemir A
    Anticancer Agents Med Chem; 2017; 17(5):674-681. PubMed ID: 27491937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.
    Becker DP; Barta TE; Bedell L; DeCrescenzo G; Freskos J; Getman DP; Hockerman SL; Li M; Mehta P; Mischke B; Munie GE; Swearingen C; Villamil CI
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2719-22. PubMed ID: 11591509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.